NEAR DEATH PATEINTS NEED TREATMENT- FILL THE LL TRIAL
Post# of 148184
JUST FILL THE DARN TRIAL. There are 43,000 investor/advocates!
Novel Drug Leronlimab has FDA-Approved Phase 3 Clinical Trials for Near Death COVID-19 Patients Filling Up as Infections and Deaths Soar.
FDA COVID Severe/Critical Clinical Trial Data for Leronlimab: https://clinicaltrials.gov/ct2/show/NCT04347239FDA COVID Severe/Critical Clinical Trial Sites for Leronlimab:
https://www.cytodyn.com/clinical-trial-enroll...r-critical
New Drug for Near-Death COVID-19 Patients in Seeking FDA Approval with Over 300,000 Doses of Leronlimab in Stock, 800K More Being Made CytoDyn, Inc This Year.
Samsung Biologics Manufacturing Leronlimab for COVID-19 Treatment (08/19/20 update)https://www.cytodyn.com/clinical-trial-enrollment/covid-19-severe-or-critical
Novel New Drug Leronlimab for Near Death COVID-19 Patients Seeks Approval Assistance from both Trump Administration and Biden Transition Team
Novel Drug Leronlimab Shows Positive Data for Near-Death Covid Patients: 195 patients in Phase 2/3 Clinical Trial Interim Data, 63 patients in Right-to-Try Case Data and 10 patients in Int. Journal of Infectious Disease paper Mechanism of Action.
Positive Phase 2/3 DSMC Recommendation https://www.cytodyn.com/investors/news-events...er-interim
"Given the role of CCR5 in immune cell migration and inflammation, we investigated the impact of CCR5 blockade via the CCR5-specific antibody leronlimab on clinical, immunological and virological parameters in patients with severe COVID-19 disease. "
https://www.sciencedirect.com/science/article...1220323055